Friday 6 November 2026 Export TVTX’s income statement to Excel — free account

Travere Therapeutics, Inc.

Travere Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $490.7 million, up 110.5% from fiscal 2024.

Revenue: +36.2%
EPS: −290.7%
Free cash flow: +6,379.8%
Total debt: +93.8%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

49.45 0.58 +1.19%

Follow TVTX

Alert me

Market cap: $4.7B
P/E: 0.0×
Fwd P/E: −145×
Dividend yield: —
F-score: 6/9
Altman Z: 1.78
Beneish M: −1.74
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	6	6	5
ROE Full definition →		(29.38%)	(32.57%)	(151.79%)	(252.75%)
ROA Full definition →		(4.26%)	(3.88%)	(6.42%)	(17.52%)
ROIC Full definition →		(37.84%)	(24.41%)	(18.31%)	(54.08%)
Return on Tangible Assets Full definition →		(9.07%)	(7.91%)	(9.32%)	(28.57%)
Average Days of Receivables Full definition →		59.60	59.43	49.77	60.29
Free Cash Flow per Share Full definition →		(0.23)	(0.31)	0.16	0.90
Free Cash Flow Full definition →		(20.37)	(28.94)	15.16	85.35
Capital Expenditures Full definition →		(58.16)	(68.55)	(77.54)	(91.24)
Other line items
Cash ROIC Full definition →		(2.72%)	(4.28%)	1.36%	7.77%
Accounts Receivable Turnover Full definition →		9.15	8.81	9.91	6.83
Accounts Payable Turnover Full definition →		0.43	0.54	0.62	0.57
Inventory Turnover Full definition →		1.71	1.48	1.39	1.19
Average Days of Payables Full definition →		875.52	619.30	331.08	584.46
Days of Inventory on Hand Full definition →		207.41	304.85	346.09	402.13
Tax Rate Full definition →		0.02	0.02	0.01	(0.03)
Research and Development Expense of Revenue Full definition →		41.98%	40.32%	38.41%	55.09%
Selling, General and Administrative Expense of Revenue Full definition →		68.71%	66.59%	66.05%	61.83%
Share Based Compensation of Revenue Full definition →		9.14%	9.24%	10.26%	11.19%
Interest Coverage Full definition →		(5.85)	(5.60)	(4.27)	(15.05)
Operating CF/Net income Full definition →		(1.48)	(1.85)	(2.13)	(1.45)
Depreciation/Fixed assets Full definition →		14.41	19.40	18.75	18.35
Capex/Depreciation Full definition →		(1.00)	(0.97)	(1.28)	(1.83)
Revenue per Share Full definition →		5.50	5.84	6.33	6.88
Operating CF per Share Full definition →		0.42	0.43	0.99	1.87
Capex per Share Full definition →		(0.65)	(0.75)	(0.83)	(0.96)
Capex to Sales Full definition →		0.12	0.13	0.13	0.14

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly